# Upfront Lipid-Lowering Therapy With Statins Combined With Hybutimibe in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.

Study · id `cardio:ct-nct07908875` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07908875](<https://clinicaltrials.gov/study/NCT07908875>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07908875

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 520 participants.

## Technical summary

Registry record NCT07908875. Randomized; single masking; primary purpose treatment. Start 2026-11-30 (anticipated); primary completion 2027-09-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 520 participants (planned count; ClinicalTrials.gov record NCT07908875, source copy `cardio:ctgov-nct07908875-2026-11-04`, retrieved 2026-11-18)
- Planned start: 2026-11-30 (anticipated) (ClinicalTrials.gov record NCT07908875, source copy `cardio:ctgov-nct07908875-2026-11-04`, retrieved 2026-11-18)
- Primary completion: 2027-09-30 (anticipated) (ClinicalTrials.gov record NCT07908875, source copy `cardio:ctgov-nct07908875-2026-11-04`, retrieved 2026-11-18)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07908875, source copy `cardio:ctgov-nct07908875-2026-11-04`, retrieved 2026-11-18)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07908875-2026-11-04`, retrieved 2026-11-18)

## The registry's words

- Brief title: Upfront Lipid-Lowering Therapy With Statins Combined With Hybutimibe in Patients With Acute Ischemic Stroke or Transient Ischemic Attack.
- Condition: Ischemia Stroke
- Condition: TIA (Transient Ischemic Attack)
- Intervention (Drug): Atorvastatin
- Intervention (Drug): Hybutimibe 10mg QD
- Lead sponsor: First Affiliated Hospital of Wannan Medical College
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Transient ischemic attack (mini-stroke) (`cardio:transient-ischemic-attack`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Atorvastatin (`cardio:atorvastatin`)
- Registry lists this organization as the lead sponsor: First Affiliated Hospital of Wannan Medical College (`cardio:org-first-affiliated-hospital-of-wannan-medical-college`)

## Provenance

Content hash: 7fff621de62c54faa0e868521638f7212663a793a022d7a0c84f4a82aaffca30
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
